trial

Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations

NCTId NCT02525315
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 15 (actual)
Sponsored by University Hospital, Caen
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2007-06
Primary completion
2012-06
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Transcranial magnetic stimulation: rTMS

Sponsors

University Hospital, CaenLead Sponsor

Investigators

1
Sonia Dollfus, MD, PhDPrincipal Investigator

Sites

1 total
Caen, France

Linked catalysts

1
Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment — primary completion2012-06

Facts & assertions

4 sourced
Enrollment
15
Phase
PHASE2
Primary Completion Date
2012-06
Status
COMPLETED
relationships
The graph out of here
drug
Transcranial magnetic stimulation: rTMS
drug
lead_sponsor
University Hospital, Caen
company
indication
Schizophrenic Disorders
indication
Hallucinations
indication
Schizophrenia
indication
investigator
Sonia Dollfus, MD, PhD
person